Publication Details
Abstract
This study focuses on the development of "Fatufiltrum" granules, a comprehensive enterosorbent drug based on purified and activated glauconite. Enterosorbents are essential for detoxification in medical treatments, yet improved formulations are needed to enhance efficacy. The research addresses this gap by creating a scientifically substantiated composition containing activated glauconite, dry extract of common chicory, L-carnitine, and chromium picolinate. The granules were developed using a novel technology, and their qualitative indicators and sorption capacity were thoroughly investigated. Results demonstrate that "Fatufiltrum" has promising potential as an effective enterosorbent, with implications for advancing detoxification treatments.